nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP3A4—Everolimus—kidney cancer	0.0877	0.128	CbGbCtD
Trimethadione—CYP2C8—Pazopanib—kidney cancer	0.0768	0.112	CbGbCtD
Trimethadione—CYP3A4—Temsirolimus—kidney cancer	0.0593	0.0865	CbGbCtD
Trimethadione—CYP2C9—Capecitabine—kidney cancer	0.0558	0.0815	CbGbCtD
Trimethadione—CYP2C8—Erlotinib—kidney cancer	0.0548	0.0799	CbGbCtD
Trimethadione—CYP2C8—Paclitaxel—kidney cancer	0.0501	0.0732	CbGbCtD
Trimethadione—CYP2C8—Sorafenib—kidney cancer	0.0445	0.065	CbGbCtD
Trimethadione—CYP2C19—Sorafenib—kidney cancer	0.0374	0.0545	CbGbCtD
Trimethadione—CYP2C9—Paclitaxel—kidney cancer	0.035	0.051	CbGbCtD
Trimethadione—CYP3A4—Pazopanib—kidney cancer	0.0311	0.0454	CbGbCtD
Trimethadione—CYP2C9—Sorafenib—kidney cancer	0.0311	0.0453	CbGbCtD
Trimethadione—CYP3A4—Erlotinib—kidney cancer	0.0222	0.0324	CbGbCtD
Trimethadione—CYP3A4—Paclitaxel—kidney cancer	0.0203	0.0297	CbGbCtD
Trimethadione—CYP3A4—Sorafenib—kidney cancer	0.0181	0.0264	CbGbCtD
Trimethadione—CYP3A4—Vinblastine—kidney cancer	0.0178	0.026	CbGbCtD
Trimethadione—CYP3A4—Vincristine—kidney cancer	0.0175	0.0256	CbGbCtD
Trimethadione—CYP3A4—Sunitinib—kidney cancer	0.0146	0.0214	CbGbCtD
Trimethadione—CYP3A4—Doxorubicin—kidney cancer	0.011	0.016	CbGbCtD
Trimethadione—CYP2C19—urine—kidney cancer	0.00216	0.221	CbGeAlD
Trimethadione—CYP2C9—urine—kidney cancer	0.00167	0.171	CbGeAlD
Trimethadione—CYP2E1—urine—kidney cancer	0.00159	0.162	CbGeAlD
Trimethadione—CYP3A4—urine—kidney cancer	0.00128	0.131	CbGeAlD
Trimethadione—Gastrointestinal pain—Pazopanib—kidney cancer	0.000711	0.00279	CcSEcCtD
Trimethadione—Discomfort—Vinblastine—kidney cancer	0.00071	0.00279	CcSEcCtD
Trimethadione—Discomfort—Everolimus—kidney cancer	0.000707	0.00278	CcSEcCtD
Trimethadione—Abdominal pain—Pazopanib—kidney cancer	0.000687	0.0027	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Capecitabine—kidney cancer	0.000681	0.00268	CcSEcCtD
Trimethadione—Alopecia—Dactinomycin—kidney cancer	0.000675	0.00265	CcSEcCtD
Trimethadione—Thrombocytopenia—Vinblastine—kidney cancer	0.000675	0.00265	CcSEcCtD
Trimethadione—Agranulocytosis—Gemcitabine—kidney cancer	0.000673	0.00264	CcSEcCtD
Trimethadione—Thrombocytopenia—Everolimus—kidney cancer	0.000672	0.00264	CcSEcCtD
Trimethadione—Asthenia—Temsirolimus—kidney cancer	0.000662	0.0026	CcSEcCtD
Trimethadione—Anorexia—Vinblastine—kidney cancer	0.000657	0.00258	CcSEcCtD
Trimethadione—Anorexia—Everolimus—kidney cancer	0.000654	0.00257	CcSEcCtD
Trimethadione—Leukopenia—Sorafenib—kidney cancer	0.000653	0.00257	CcSEcCtD
Trimethadione—Pruritus—Temsirolimus—kidney cancer	0.000653	0.00256	CcSEcCtD
Trimethadione—Haemoglobin—Gemcitabine—kidney cancer	0.000651	0.00256	CcSEcCtD
Trimethadione—Thrombocytopenia—Erlotinib—kidney cancer	0.000648	0.00255	CcSEcCtD
Trimethadione—Haemorrhage—Gemcitabine—kidney cancer	0.000647	0.00254	CcSEcCtD
Trimethadione—Pancytopenia—Paclitaxel—kidney cancer	0.000643	0.00253	CcSEcCtD
Trimethadione—Diplopia—Capecitabine—kidney cancer	0.000643	0.00253	CcSEcCtD
Trimethadione—Neutropenia—Paclitaxel—kidney cancer	0.000633	0.00249	CcSEcCtD
Trimethadione—Anorexia—Erlotinib—kidney cancer	0.000631	0.00248	CcSEcCtD
Trimethadione—Leukopenia—Sunitinib—kidney cancer	0.000629	0.00247	CcSEcCtD
Trimethadione—Asthenia—Pazopanib—kidney cancer	0.000624	0.00245	CcSEcCtD
Trimethadione—Insomnia—Everolimus—kidney cancer	0.000621	0.00244	CcSEcCtD
Trimethadione—Paraesthesia—Vinblastine—kidney cancer	0.000619	0.00243	CcSEcCtD
Trimethadione—Ill-defined disorder—Dactinomycin—kidney cancer	0.000617	0.00242	CcSEcCtD
Trimethadione—Paraesthesia—Everolimus—kidney cancer	0.000616	0.00242	CcSEcCtD
Trimethadione—Pruritus—Pazopanib—kidney cancer	0.000615	0.00242	CcSEcCtD
Trimethadione—Irritability—Capecitabine—kidney cancer	0.000614	0.00241	CcSEcCtD
Trimethadione—Weight decreased—Paclitaxel—kidney cancer	0.000613	0.00241	CcSEcCtD
Trimethadione—Erythema multiforme—Gemcitabine—kidney cancer	0.000612	0.0024	CcSEcCtD
Trimethadione—Somnolence—Everolimus—kidney cancer	0.00061	0.0024	CcSEcCtD
Trimethadione—Alopecia—Vincristine—kidney cancer	0.000603	0.00237	CcSEcCtD
Trimethadione—Malaise—Dactinomycin—kidney cancer	0.0006	0.00235	CcSEcCtD
Trimethadione—Insomnia—Erlotinib—kidney cancer	0.000599	0.00235	CcSEcCtD
Trimethadione—Decreased appetite—Vinblastine—kidney cancer	0.000599	0.00235	CcSEcCtD
Trimethadione—Decreased appetite—Everolimus—kidney cancer	0.000597	0.00234	CcSEcCtD
Trimethadione—Leukopenia—Dactinomycin—kidney cancer	0.000595	0.00234	CcSEcCtD
Trimethadione—Fatigue—Everolimus—kidney cancer	0.000592	0.00232	CcSEcCtD
Trimethadione—Vomiting—Temsirolimus—kidney cancer	0.000587	0.0023	CcSEcCtD
Trimethadione—Thrombocytopenia—Sorafenib—kidney cancer	0.000583	0.00229	CcSEcCtD
Trimethadione—Rash—Temsirolimus—kidney cancer	0.000582	0.00228	CcSEcCtD
Trimethadione—Dermatitis—Temsirolimus—kidney cancer	0.000581	0.00228	CcSEcCtD
Trimethadione—Headache—Temsirolimus—kidney cancer	0.000578	0.00227	CcSEcCtD
Trimethadione—Decreased appetite—Erlotinib—kidney cancer	0.000576	0.00226	CcSEcCtD
Trimethadione—Alopecia—Gemcitabine—kidney cancer	0.000572	0.00225	CcSEcCtD
Trimethadione—Hiccups—Doxorubicin—kidney cancer	0.000571	0.00224	CcSEcCtD
Trimethadione—Fatigue—Erlotinib—kidney cancer	0.000571	0.00224	CcSEcCtD
Trimethadione—Epistaxis—Paclitaxel—kidney cancer	0.00057	0.00224	CcSEcCtD
Trimethadione—Anorexia—Sorafenib—kidney cancer	0.000568	0.00223	CcSEcCtD
Trimethadione—Feeling abnormal—Vinblastine—kidney cancer	0.000568	0.00223	CcSEcCtD
Trimethadione—Feeling abnormal—Everolimus—kidney cancer	0.000566	0.00222	CcSEcCtD
Trimethadione—Gastrointestinal pain—Vinblastine—kidney cancer	0.000563	0.00221	CcSEcCtD
Trimethadione—Thrombocytopenia—Sunitinib—kidney cancer	0.000561	0.0022	CcSEcCtD
Trimethadione—Gastrointestinal pain—Everolimus—kidney cancer	0.000561	0.0022	CcSEcCtD
Trimethadione—Discomfort—Dactinomycin—kidney cancer	0.000559	0.0022	CcSEcCtD
Trimethadione—Vomiting—Pazopanib—kidney cancer	0.000553	0.00217	CcSEcCtD
Trimethadione—Rash—Pazopanib—kidney cancer	0.000548	0.00215	CcSEcCtD
Trimethadione—Nausea—Temsirolimus—kidney cancer	0.000548	0.00215	CcSEcCtD
Trimethadione—Dermatitis—Pazopanib—kidney cancer	0.000548	0.00215	CcSEcCtD
Trimethadione—Anorexia—Sunitinib—kidney cancer	0.000546	0.00215	CcSEcCtD
Trimethadione—Haemoglobin—Paclitaxel—kidney cancer	0.000545	0.00214	CcSEcCtD
Trimethadione—Abdominal pain—Vinblastine—kidney cancer	0.000545	0.00214	CcSEcCtD
Trimethadione—Headache—Pazopanib—kidney cancer	0.000545	0.00214	CcSEcCtD
Trimethadione—Abdominal pain—Everolimus—kidney cancer	0.000543	0.00213	CcSEcCtD
Trimethadione—Haemorrhage—Paclitaxel—kidney cancer	0.000542	0.00213	CcSEcCtD
Trimethadione—Gastrointestinal pain—Erlotinib—kidney cancer	0.000541	0.00213	CcSEcCtD
Trimethadione—Aplastic anaemia—Doxorubicin—kidney cancer	0.000536	0.00211	CcSEcCtD
Trimethadione—Vertigo—Vincristine—kidney cancer	0.000534	0.0021	CcSEcCtD
Trimethadione—Leukopenia—Vincristine—kidney cancer	0.000532	0.00209	CcSEcCtD
Trimethadione—Thrombocytopenia—Dactinomycin—kidney cancer	0.000531	0.00209	CcSEcCtD
Trimethadione—Pancytopenia—Capecitabine—kidney cancer	0.000528	0.00207	CcSEcCtD
Trimethadione—Abdominal pain—Erlotinib—kidney cancer	0.000523	0.00206	CcSEcCtD
Trimethadione—Ill-defined disorder—Gemcitabine—kidney cancer	0.000523	0.00205	CcSEcCtD
Trimethadione—Neutropenia—Capecitabine—kidney cancer	0.00052	0.00204	CcSEcCtD
Trimethadione—Insomnia—Sunitinib—kidney cancer	0.000518	0.00204	CcSEcCtD
Trimethadione—Decreased appetite—Sorafenib—kidney cancer	0.000518	0.00203	CcSEcCtD
Trimethadione—Anorexia—Dactinomycin—kidney cancer	0.000517	0.00203	CcSEcCtD
Trimethadione—Nausea—Pazopanib—kidney cancer	0.000516	0.00203	CcSEcCtD
Trimethadione—Paraesthesia—Sunitinib—kidney cancer	0.000515	0.00202	CcSEcCtD
Trimethadione—Fatigue—Sorafenib—kidney cancer	0.000514	0.00202	CcSEcCtD
Trimethadione—Erythema multiforme—Paclitaxel—kidney cancer	0.000513	0.00201	CcSEcCtD
Trimethadione—Malaise—Gemcitabine—kidney cancer	0.000508	0.002	CcSEcCtD
Trimethadione—Leukopenia—Gemcitabine—kidney cancer	0.000504	0.00198	CcSEcCtD
Trimethadione—Weight decreased—Capecitabine—kidney cancer	0.000503	0.00197	CcSEcCtD
Trimethadione—Decreased appetite—Sunitinib—kidney cancer	0.000498	0.00196	CcSEcCtD
Trimethadione—Asthenia—Vinblastine—kidney cancer	0.000494	0.00194	CcSEcCtD
Trimethadione—Fatigue—Sunitinib—kidney cancer	0.000494	0.00194	CcSEcCtD
Trimethadione—Asthenia—Everolimus—kidney cancer	0.000492	0.00193	CcSEcCtD
Trimethadione—Gastrointestinal pain—Sorafenib—kidney cancer	0.000487	0.00191	CcSEcCtD
Trimethadione—Lymphadenopathy—Doxorubicin—kidney cancer	0.000486	0.00191	CcSEcCtD
Trimethadione—Pruritus—Everolimus—kidney cancer	0.000486	0.00191	CcSEcCtD
Trimethadione—Alopecia—Paclitaxel—kidney cancer	0.000479	0.00188	CcSEcCtD
Trimethadione—Asthenia—Erlotinib—kidney cancer	0.000475	0.00187	CcSEcCtD
Trimethadione—Thrombocytopenia—Vincristine—kidney cancer	0.000475	0.00186	CcSEcCtD
Trimethadione—Discomfort—Gemcitabine—kidney cancer	0.000474	0.00186	CcSEcCtD
Trimethadione—Decreased appetite—Dactinomycin—kidney cancer	0.000472	0.00185	CcSEcCtD
Trimethadione—Abdominal pain—Sorafenib—kidney cancer	0.000471	0.00185	CcSEcCtD
Trimethadione—Gastrointestinal pain—Sunitinib—kidney cancer	0.000469	0.00184	CcSEcCtD
Trimethadione—Pruritus—Erlotinib—kidney cancer	0.000468	0.00184	CcSEcCtD
Trimethadione—Fatigue—Dactinomycin—kidney cancer	0.000468	0.00184	CcSEcCtD
Trimethadione—Epistaxis—Capecitabine—kidney cancer	0.000467	0.00184	CcSEcCtD
Trimethadione—Agranulocytosis—Capecitabine—kidney cancer	0.000462	0.00182	CcSEcCtD
Trimethadione—Anorexia—Vincristine—kidney cancer	0.000462	0.00182	CcSEcCtD
Trimethadione—CYP2C8—renal system—kidney cancer	0.000461	0.0472	CbGeAlD
Trimethadione—Abdominal pain—Sunitinib—kidney cancer	0.000453	0.00178	CcSEcCtD
Trimethadione—Thrombocytopenia—Gemcitabine—kidney cancer	0.00045	0.00177	CcSEcCtD
Trimethadione—Feeling abnormal—Dactinomycin—kidney cancer	0.000447	0.00176	CcSEcCtD
Trimethadione—Haemoglobin—Capecitabine—kidney cancer	0.000447	0.00176	CcSEcCtD
Trimethadione—CYP2C8—kidney—kidney cancer	0.000446	0.0456	CbGeAlD
Trimethadione—Hepatitis—Capecitabine—kidney cancer	0.000445	0.00175	CcSEcCtD
Trimethadione—Haemorrhage—Capecitabine—kidney cancer	0.000445	0.00175	CcSEcCtD
Trimethadione—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000444	0.00174	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000439	0.00173	CcSEcCtD
Trimethadione—Insomnia—Vincristine—kidney cancer	0.000439	0.00172	CcSEcCtD
Trimethadione—Anorexia—Gemcitabine—kidney cancer	0.000438	0.00172	CcSEcCtD
Trimethadione—Vomiting—Vinblastine—kidney cancer	0.000438	0.00172	CcSEcCtD
Trimethadione—Ill-defined disorder—Paclitaxel—kidney cancer	0.000438	0.00172	CcSEcCtD
Trimethadione—Vomiting—Everolimus—kidney cancer	0.000436	0.00171	CcSEcCtD
Trimethadione—Paraesthesia—Vincristine—kidney cancer	0.000435	0.00171	CcSEcCtD
Trimethadione—Rash—Everolimus—kidney cancer	0.000433	0.0017	CcSEcCtD
Trimethadione—Dermatitis—Everolimus—kidney cancer	0.000432	0.0017	CcSEcCtD
Trimethadione—Headache—Vinblastine—kidney cancer	0.000432	0.00169	CcSEcCtD
Trimethadione—Headache—Everolimus—kidney cancer	0.00043	0.00169	CcSEcCtD
Trimethadione—Abdominal pain—Dactinomycin—kidney cancer	0.000429	0.00168	CcSEcCtD
Trimethadione—Asthenia—Sorafenib—kidney cancer	0.000427	0.00168	CcSEcCtD
Trimethadione—CYP2E1—nephron tubule—kidney cancer	0.000427	0.0437	CbGeAlD
Trimethadione—Malaise—Paclitaxel—kidney cancer	0.000426	0.00167	CcSEcCtD
Trimethadione—Vertigo—Paclitaxel—kidney cancer	0.000424	0.00166	CcSEcCtD
Trimethadione—Leukopenia—Paclitaxel—kidney cancer	0.000422	0.00166	CcSEcCtD
Trimethadione—Decreased appetite—Vincristine—kidney cancer	0.000421	0.00166	CcSEcCtD
Trimethadione—Pruritus—Sorafenib—kidney cancer	0.000421	0.00166	CcSEcCtD
Trimethadione—Vomiting—Erlotinib—kidney cancer	0.000421	0.00165	CcSEcCtD
Trimethadione—Erythema multiforme—Capecitabine—kidney cancer	0.000421	0.00165	CcSEcCtD
Trimethadione—Fatigue—Vincristine—kidney cancer	0.000418	0.00164	CcSEcCtD
Trimethadione—Rash—Erlotinib—kidney cancer	0.000418	0.00164	CcSEcCtD
Trimethadione—Dermatitis—Erlotinib—kidney cancer	0.000417	0.00164	CcSEcCtD
Trimethadione—Insomnia—Gemcitabine—kidney cancer	0.000416	0.00163	CcSEcCtD
Trimethadione—Headache—Erlotinib—kidney cancer	0.000415	0.00163	CcSEcCtD
Trimethadione—Diplopia—Doxorubicin—kidney cancer	0.000414	0.00163	CcSEcCtD
Trimethadione—Paraesthesia—Gemcitabine—kidney cancer	0.000413	0.00162	CcSEcCtD
Trimethadione—Asthenia—Sunitinib—kidney cancer	0.000411	0.00162	CcSEcCtD
Trimethadione—Nausea—Vinblastine—kidney cancer	0.000409	0.00161	CcSEcCtD
Trimethadione—Somnolence—Gemcitabine—kidney cancer	0.000409	0.00161	CcSEcCtD
Trimethadione—Nausea—Everolimus—kidney cancer	0.000408	0.0016	CcSEcCtD
Trimethadione—Pruritus—Sunitinib—kidney cancer	0.000406	0.00159	CcSEcCtD
Trimethadione—Decreased appetite—Gemcitabine—kidney cancer	0.0004	0.00157	CcSEcCtD
Trimethadione—Discomfort—Paclitaxel—kidney cancer	0.000397	0.00156	CcSEcCtD
Trimethadione—Fatigue—Gemcitabine—kidney cancer	0.000397	0.00156	CcSEcCtD
Trimethadione—Gastrointestinal pain—Vincristine—kidney cancer	0.000396	0.00156	CcSEcCtD
Trimethadione—Nausea—Erlotinib—kidney cancer	0.000393	0.00154	CcSEcCtD
Trimethadione—Alopecia—Capecitabine—kidney cancer	0.000393	0.00154	CcSEcCtD
Trimethadione—Asthenia—Dactinomycin—kidney cancer	0.000389	0.00153	CcSEcCtD
Trimethadione—CYP2E1—renal system—kidney cancer	0.000388	0.0397	CbGeAlD
Trimethadione—Abdominal pain—Vincristine—kidney cancer	0.000383	0.00151	CcSEcCtD
Trimethadione—Feeling abnormal—Gemcitabine—kidney cancer	0.000379	0.00149	CcSEcCtD
Trimethadione—Vomiting—Sorafenib—kidney cancer	0.000379	0.00149	CcSEcCtD
Trimethadione—Thrombocytopenia—Paclitaxel—kidney cancer	0.000377	0.00148	CcSEcCtD
Trimethadione—Rash—Sorafenib—kidney cancer	0.000376	0.00148	CcSEcCtD
Trimethadione—CYP2E1—kidney—kidney cancer	0.000375	0.0384	CbGeAlD
Trimethadione—Dermatitis—Sorafenib—kidney cancer	0.000375	0.00147	CcSEcCtD
Trimethadione—Headache—Sorafenib—kidney cancer	0.000373	0.00147	CcSEcCtD
Trimethadione—Anorexia—Paclitaxel—kidney cancer	0.000367	0.00144	CcSEcCtD
Trimethadione—CYP2E1—cortex of kidney—kidney cancer	0.000366	0.0374	CbGeAlD
Trimethadione—Vomiting—Sunitinib—kidney cancer	0.000364	0.00143	CcSEcCtD
Trimethadione—Rash—Sunitinib—kidney cancer	0.000361	0.00142	CcSEcCtD
Trimethadione—Dermatitis—Sunitinib—kidney cancer	0.000361	0.00142	CcSEcCtD
Trimethadione—Ill-defined disorder—Capecitabine—kidney cancer	0.000359	0.00141	CcSEcCtD
Trimethadione—Headache—Sunitinib—kidney cancer	0.000359	0.00141	CcSEcCtD
Trimethadione—Eosinophilia—Doxorubicin—kidney cancer	0.000355	0.00139	CcSEcCtD
Trimethadione—Nausea—Sorafenib—kidney cancer	0.000354	0.00139	CcSEcCtD
Trimethadione—Malaise—Capecitabine—kidney cancer	0.000349	0.00137	CcSEcCtD
Trimethadione—Insomnia—Paclitaxel—kidney cancer	0.000348	0.00137	CcSEcCtD
Trimethadione—Vertigo—Capecitabine—kidney cancer	0.000348	0.00137	CcSEcCtD
Trimethadione—Asthenia—Vincristine—kidney cancer	0.000348	0.00137	CcSEcCtD
Trimethadione—Leukopenia—Capecitabine—kidney cancer	0.000347	0.00136	CcSEcCtD
Trimethadione—Paraesthesia—Paclitaxel—kidney cancer	0.000346	0.00136	CcSEcCtD
Trimethadione—Vomiting—Dactinomycin—kidney cancer	0.000345	0.00136	CcSEcCtD
Trimethadione—Somnolence—Paclitaxel—kidney cancer	0.000342	0.00134	CcSEcCtD
Trimethadione—Rash—Dactinomycin—kidney cancer	0.000342	0.00134	CcSEcCtD
Trimethadione—Nausea—Sunitinib—kidney cancer	0.00034	0.00134	CcSEcCtD
Trimethadione—Pancytopenia—Doxorubicin—kidney cancer	0.00034	0.00134	CcSEcCtD
Trimethadione—Neutropenia—Doxorubicin—kidney cancer	0.000335	0.00132	CcSEcCtD
Trimethadione—Decreased appetite—Paclitaxel—kidney cancer	0.000335	0.00131	CcSEcCtD
Trimethadione—Fatigue—Paclitaxel—kidney cancer	0.000332	0.0013	CcSEcCtD
Trimethadione—Asthenia—Gemcitabine—kidney cancer	0.00033	0.0013	CcSEcCtD
Trimethadione—Discomfort—Capecitabine—kidney cancer	0.000326	0.00128	CcSEcCtD
Trimethadione—Pruritus—Gemcitabine—kidney cancer	0.000325	0.00128	CcSEcCtD
Trimethadione—Weight decreased—Doxorubicin—kidney cancer	0.000324	0.00127	CcSEcCtD
Trimethadione—Nausea—Dactinomycin—kidney cancer	0.000322	0.00127	CcSEcCtD
Trimethadione—Drowsiness—Doxorubicin—kidney cancer	0.000319	0.00125	CcSEcCtD
Trimethadione—Feeling abnormal—Paclitaxel—kidney cancer	0.000317	0.00125	CcSEcCtD
Trimethadione—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000315	0.00124	CcSEcCtD
Trimethadione—CYP3A4—renal system—kidney cancer	0.000312	0.0319	CbGeAlD
Trimethadione—Thrombocytopenia—Capecitabine—kidney cancer	0.000309	0.00122	CcSEcCtD
Trimethadione—Vomiting—Vincristine—kidney cancer	0.000308	0.00121	CcSEcCtD
Trimethadione—Rash—Vincristine—kidney cancer	0.000306	0.0012	CcSEcCtD
Trimethadione—Dermatitis—Vincristine—kidney cancer	0.000305	0.0012	CcSEcCtD
Trimethadione—Abdominal pain—Paclitaxel—kidney cancer	0.000304	0.0012	CcSEcCtD
Trimethadione—Headache—Vincristine—kidney cancer	0.000304	0.00119	CcSEcCtD
Trimethadione—CYP3A4—kidney—kidney cancer	0.000302	0.0309	CbGeAlD
Trimethadione—Epistaxis—Doxorubicin—kidney cancer	0.000301	0.00118	CcSEcCtD
Trimethadione—Anorexia—Capecitabine—kidney cancer	0.000301	0.00118	CcSEcCtD
Trimethadione—Agranulocytosis—Doxorubicin—kidney cancer	0.000298	0.00117	CcSEcCtD
Trimethadione—Vomiting—Gemcitabine—kidney cancer	0.000292	0.00115	CcSEcCtD
Trimethadione—Rash—Gemcitabine—kidney cancer	0.00029	0.00114	CcSEcCtD
Trimethadione—Dermatitis—Gemcitabine—kidney cancer	0.00029	0.00114	CcSEcCtD
Trimethadione—Haemoglobin—Doxorubicin—kidney cancer	0.000288	0.00113	CcSEcCtD
Trimethadione—Headache—Gemcitabine—kidney cancer	0.000288	0.00113	CcSEcCtD
Trimethadione—Nausea—Vincristine—kidney cancer	0.000288	0.00113	CcSEcCtD
Trimethadione—Haemorrhage—Doxorubicin—kidney cancer	0.000287	0.00113	CcSEcCtD
Trimethadione—Hepatitis—Doxorubicin—kidney cancer	0.000287	0.00113	CcSEcCtD
Trimethadione—Insomnia—Capecitabine—kidney cancer	0.000286	0.00112	CcSEcCtD
Trimethadione—Paraesthesia—Capecitabine—kidney cancer	0.000284	0.00111	CcSEcCtD
Trimethadione—Asthenia—Paclitaxel—kidney cancer	0.000276	0.00109	CcSEcCtD
Trimethadione—Decreased appetite—Capecitabine—kidney cancer	0.000275	0.00108	CcSEcCtD
Trimethadione—Nausea—Gemcitabine—kidney cancer	0.000273	0.00107	CcSEcCtD
Trimethadione—Fatigue—Capecitabine—kidney cancer	0.000272	0.00107	CcSEcCtD
Trimethadione—Pruritus—Paclitaxel—kidney cancer	0.000272	0.00107	CcSEcCtD
Trimethadione—Erythema multiforme—Doxorubicin—kidney cancer	0.000271	0.00106	CcSEcCtD
Trimethadione—Feeling abnormal—Capecitabine—kidney cancer	0.00026	0.00102	CcSEcCtD
Trimethadione—Gastrointestinal pain—Capecitabine—kidney cancer	0.000258	0.00101	CcSEcCtD
Trimethadione—Alopecia—Doxorubicin—kidney cancer	0.000253	0.000995	CcSEcCtD
Trimethadione—Abdominal pain—Capecitabine—kidney cancer	0.00025	0.000981	CcSEcCtD
Trimethadione—Vomiting—Paclitaxel—kidney cancer	0.000245	0.000962	CcSEcCtD
Trimethadione—Rash—Paclitaxel—kidney cancer	0.000243	0.000954	CcSEcCtD
Trimethadione—Dermatitis—Paclitaxel—kidney cancer	0.000243	0.000953	CcSEcCtD
Trimethadione—Headache—Paclitaxel—kidney cancer	0.000241	0.000947	CcSEcCtD
Trimethadione—Ill-defined disorder—Doxorubicin—kidney cancer	0.000232	0.00091	CcSEcCtD
Trimethadione—Nausea—Paclitaxel—kidney cancer	0.000229	0.000898	CcSEcCtD
Trimethadione—Asthenia—Capecitabine—kidney cancer	0.000227	0.00089	CcSEcCtD
Trimethadione—Malaise—Doxorubicin—kidney cancer	0.000225	0.000884	CcSEcCtD
Trimethadione—Vertigo—Doxorubicin—kidney cancer	0.000224	0.000881	CcSEcCtD
Trimethadione—Pruritus—Capecitabine—kidney cancer	0.000224	0.000878	CcSEcCtD
Trimethadione—Leukopenia—Doxorubicin—kidney cancer	0.000223	0.000877	CcSEcCtD
Trimethadione—Discomfort—Doxorubicin—kidney cancer	0.00021	0.000825	CcSEcCtD
Trimethadione—Vomiting—Capecitabine—kidney cancer	0.000201	0.000789	CcSEcCtD
Trimethadione—Thrombocytopenia—Doxorubicin—kidney cancer	0.000199	0.000783	CcSEcCtD
Trimethadione—Rash—Capecitabine—kidney cancer	0.000199	0.000783	CcSEcCtD
Trimethadione—Dermatitis—Capecitabine—kidney cancer	0.000199	0.000782	CcSEcCtD
Trimethadione—Headache—Capecitabine—kidney cancer	0.000198	0.000777	CcSEcCtD
Trimethadione—Anorexia—Doxorubicin—kidney cancer	0.000194	0.000763	CcSEcCtD
Trimethadione—Nausea—Capecitabine—kidney cancer	0.000188	0.000737	CcSEcCtD
Trimethadione—Insomnia—Doxorubicin—kidney cancer	0.000184	0.000724	CcSEcCtD
Trimethadione—Paraesthesia—Doxorubicin—kidney cancer	0.000183	0.000718	CcSEcCtD
Trimethadione—Somnolence—Doxorubicin—kidney cancer	0.000181	0.000711	CcSEcCtD
Trimethadione—Decreased appetite—Doxorubicin—kidney cancer	0.000177	0.000695	CcSEcCtD
Trimethadione—Fatigue—Doxorubicin—kidney cancer	0.000176	0.00069	CcSEcCtD
Trimethadione—Feeling abnormal—Doxorubicin—kidney cancer	0.000168	0.000659	CcSEcCtD
Trimethadione—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000167	0.000654	CcSEcCtD
Trimethadione—Abdominal pain—Doxorubicin—kidney cancer	0.000161	0.000632	CcSEcCtD
Trimethadione—Asthenia—Doxorubicin—kidney cancer	0.000146	0.000574	CcSEcCtD
Trimethadione—Pruritus—Doxorubicin—kidney cancer	0.000144	0.000566	CcSEcCtD
Trimethadione—Vomiting—Doxorubicin—kidney cancer	0.00013	0.000509	CcSEcCtD
Trimethadione—Rash—Doxorubicin—kidney cancer	0.000128	0.000504	CcSEcCtD
Trimethadione—Dermatitis—Doxorubicin—kidney cancer	0.000128	0.000504	CcSEcCtD
Trimethadione—Headache—Doxorubicin—kidney cancer	0.000128	0.000501	CcSEcCtD
Trimethadione—Nausea—Doxorubicin—kidney cancer	0.000121	0.000475	CcSEcCtD
Trimethadione—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	7.53e-05	0.00149	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK3—kidney cancer	7.43e-05	0.00147	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—RAF1—kidney cancer	7.36e-05	0.00146	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—RELA—kidney cancer	7.33e-05	0.00145	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—ERBB2—kidney cancer	7.28e-05	0.00144	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	7.24e-05	0.00144	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTP1—kidney cancer	7.18e-05	0.00142	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.15e-05	0.00142	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	7.14e-05	0.00142	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	7.09e-05	0.0014	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MAPK1—kidney cancer	7.07e-05	0.0014	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.97e-05	0.00138	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—KRAS—kidney cancer	6.68e-05	0.00132	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTM1—kidney cancer	6.6e-05	0.00131	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	6.51e-05	0.00129	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTP1—kidney cancer	6.41e-05	0.00127	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—CTNNB1—kidney cancer	6.37e-05	0.00126	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ACY1—kidney cancer	6.37e-05	0.00126	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	6.32e-05	0.00125	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.32e-05	0.00125	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	6.26e-05	0.00124	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	6.17e-05	0.00122	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTM1—kidney cancer	5.89e-05	0.00117	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTP1—kidney cancer	5.85e-05	0.00116	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.82e-05	0.00115	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	5.81e-05	0.00115	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	5.77e-05	0.00114	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—VEGFA—kidney cancer	5.61e-05	0.00111	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	5.59e-05	0.00111	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5.56e-05	0.0011	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	5.51e-05	0.00109	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ACY1—kidney cancer	5.51e-05	0.00109	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PDHB—kidney cancer	5.42e-05	0.00107	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—POMC—kidney cancer	5.4e-05	0.00107	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTM1—kidney cancer	5.37e-05	0.00107	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK3—kidney cancer	5.31e-05	0.00105	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	5.3e-05	0.00105	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—PTGS1—kidney cancer	5.21e-05	0.00103	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	5.09e-05	0.00101	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CCBL1—kidney cancer	5.09e-05	0.00101	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MAPK1—kidney cancer	5.05e-05	0.001	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	5.02e-05	0.000996	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ACY1—kidney cancer	4.91e-05	0.000974	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—KRAS—kidney cancer	4.77e-05	0.000945	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.72e-05	0.000935	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.69e-05	0.000931	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PDHB—kidney cancer	4.68e-05	0.000928	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—POMC—kidney cancer	4.67e-05	0.000925	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ACY1—kidney cancer	4.48e-05	0.000888	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GLIPR1—kidney cancer	4.41e-05	0.000875	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PPAT—kidney cancer	4.41e-05	0.000875	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CCBL1—kidney cancer	4.4e-05	0.000872	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.19e-05	0.000831	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PDHB—kidney cancer	4.18e-05	0.000828	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—POMC—kidney cancer	4.17e-05	0.000826	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—FH—kidney cancer	4.1e-05	0.000814	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—APRT—kidney cancer	4.1e-05	0.000814	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.98e-05	0.000789	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CCBL1—kidney cancer	3.93e-05	0.000779	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GPC3—kidney cancer	3.86e-05	0.000765	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.86e-05	0.000764	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.82e-05	0.000757	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GLIPR1—kidney cancer	3.82e-05	0.000756	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PPAT—kidney cancer	3.82e-05	0.000756	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PDHB—kidney cancer	3.81e-05	0.000755	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.8e-05	0.000754	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—POMC—kidney cancer	3.8e-05	0.000753	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.77e-05	0.000747	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CA2—kidney cancer	3.75e-05	0.000744	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.73e-05	0.000739	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ALAD—kidney cancer	3.66e-05	0.000725	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CCBL1—kidney cancer	3.58e-05	0.00071	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ST3GAL2—kidney cancer	3.57e-05	0.000708	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.55e-05	0.000704	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—APRT—kidney cancer	3.55e-05	0.000703	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—FH—kidney cancer	3.55e-05	0.000703	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.54e-05	0.000702	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.5e-05	0.000693	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ALDH1A1—kidney cancer	3.49e-05	0.000692	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.47e-05	0.000687	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PPAT—kidney cancer	3.41e-05	0.000675	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GLIPR1—kidney cancer	3.41e-05	0.000675	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.36e-05	0.000667	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.36e-05	0.000666	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SLC5A3—kidney cancer	3.35e-05	0.000663	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PGK1—kidney cancer	3.35e-05	0.000663	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GPC3—kidney cancer	3.34e-05	0.000661	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.33e-05	0.00066	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.31e-05	0.000657	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—LDHB—kidney cancer	3.28e-05	0.00065	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CA2—kidney cancer	3.24e-05	0.000643	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.24e-05	0.000642	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—FH—kidney cancer	3.17e-05	0.000628	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—APRT—kidney cancer	3.17e-05	0.000628	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ALAD—kidney cancer	3.16e-05	0.000627	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PPAT—kidney cancer	3.11e-05	0.000616	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.11e-05	0.000616	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.09e-05	0.000613	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ST3GAL2—kidney cancer	3.09e-05	0.000612	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.07e-05	0.000608	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.04e-05	0.000602	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ALDH1A1—kidney cancer	3.02e-05	0.000598	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GPC3—kidney cancer	2.98e-05	0.00059	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ACY1—kidney cancer	2.95e-05	0.000586	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CA2—kidney cancer	2.9e-05	0.000574	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PGK1—kidney cancer	2.89e-05	0.000573	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.89e-05	0.000573	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—FH—kidney cancer	2.89e-05	0.000572	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—APRT—kidney cancer	2.89e-05	0.000572	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CA9—kidney cancer	2.84e-05	0.000564	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—LDHB—kidney cancer	2.84e-05	0.000562	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ALAD—kidney cancer	2.82e-05	0.000559	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.82e-05	0.000559	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.75e-05	0.000546	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GPC3—kidney cancer	2.71e-05	0.000538	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.69e-05	0.000534	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CA2—kidney cancer	2.64e-05	0.000523	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PGK1—kidney cancer	2.58e-05	0.000512	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.58e-05	0.000512	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ALAD—kidney cancer	2.57e-05	0.00051	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—LDHB—kidney cancer	2.53e-05	0.000502	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PDHB—kidney cancer	2.51e-05	0.000498	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.51e-05	0.000498	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—POMC—kidney cancer	2.5e-05	0.000496	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CA9—kidney cancer	2.46e-05	0.000487	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.46e-05	0.000487	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CRABP1—kidney cancer	2.42e-05	0.000479	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.4e-05	0.000476	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CCBL1—kidney cancer	2.36e-05	0.000468	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PGK1—kidney cancer	2.35e-05	0.000467	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.35e-05	0.000467	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—LDHB—kidney cancer	2.31e-05	0.000458	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ITPR2—kidney cancer	2.25e-05	0.000446	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CA9—kidney cancer	2.19e-05	0.000435	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.15e-05	0.000425	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CRABP1—kidney cancer	2.09e-05	0.000414	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTT1—kidney cancer	2.05e-05	0.000406	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ACHE—kidney cancer	2.05e-05	0.000406	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.05e-05	0.000406	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PPAT—kidney cancer	2.05e-05	0.000406	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CA9—kidney cancer	2e-05	0.000397	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.96e-05	0.000388	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ITPR2—kidney cancer	1.94e-05	0.000385	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SCARB1—kidney cancer	1.94e-05	0.000385	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTGS1—kidney cancer	1.92e-05	0.000381	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—APRT—kidney cancer	1.9e-05	0.000377	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—FH—kidney cancer	1.9e-05	0.000377	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PSMD7—kidney cancer	1.88e-05	0.000374	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CRABP1—kidney cancer	1.87e-05	0.00037	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.79e-05	0.000355	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GPC3—kidney cancer	1.79e-05	0.000355	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—BCHE—kidney cancer	1.79e-05	0.000354	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ACHE—kidney cancer	1.77e-05	0.000351	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTT1—kidney cancer	1.77e-05	0.000351	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.76e-05	0.00035	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CA2—kidney cancer	1.74e-05	0.000345	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ITPR2—kidney cancer	1.74e-05	0.000344	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.7e-05	0.000338	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CRABP1—kidney cancer	1.7e-05	0.000337	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ALAD—kidney cancer	1.7e-05	0.000336	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SCARB1—kidney cancer	1.68e-05	0.000333	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTGS1—kidney cancer	1.66e-05	0.000329	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.66e-05	0.000328	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PSMD7—kidney cancer	1.63e-05	0.000323	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.62e-05	0.000321	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.6e-05	0.000317	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTT1—kidney cancer	1.58e-05	0.000314	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ACHE—kidney cancer	1.58e-05	0.000314	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ITPR2—kidney cancer	1.58e-05	0.000314	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PGK1—kidney cancer	1.55e-05	0.000308	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.55e-05	0.000308	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—BCHE—kidney cancer	1.54e-05	0.000306	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.53e-05	0.000302	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—LDHB—kidney cancer	1.52e-05	0.000302	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SCARB1—kidney cancer	1.5e-05	0.000297	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTGS1—kidney cancer	1.48e-05	0.000294	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.47e-05	0.000292	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.46e-05	0.000289	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PSMD7—kidney cancer	1.45e-05	0.000288	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ACHE—kidney cancer	1.44e-05	0.000286	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTT1—kidney cancer	1.44e-05	0.000286	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.43e-05	0.000283	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTP1—kidney cancer	1.42e-05	0.000282	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—BCHE—kidney cancer	1.38e-05	0.000273	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SCARB1—kidney cancer	1.37e-05	0.000271	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.36e-05	0.00027	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTGS1—kidney cancer	1.35e-05	0.000268	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ABCB1—kidney cancer	1.35e-05	0.000267	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PSMD7—kidney cancer	1.33e-05	0.000263	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CA9—kidney cancer	1.32e-05	0.000262	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.31e-05	0.000261	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTM1—kidney cancer	1.31e-05	0.000259	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.28e-05	0.000253	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—BCHE—kidney cancer	1.26e-05	0.000249	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.25e-05	0.000247	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.24e-05	0.000246	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.24e-05	0.000245	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTP1—kidney cancer	1.23e-05	0.000244	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.2e-05	0.000238	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.16e-05	0.000231	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ABCB1—kidney cancer	1.16e-05	0.000231	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTM1—kidney cancer	1.13e-05	0.000224	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CRABP1—kidney cancer	1.12e-05	0.000222	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.11e-05	0.000221	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTP1—kidney cancer	1.1e-05	0.000217	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.07e-05	0.000212	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ITPR2—kidney cancer	1.04e-05	0.000207	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ABCB1—kidney cancer	1.04e-05	0.000206	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.01e-05	0.000201	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTM1—kidney cancer	1.01e-05	0.0002	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTP1—kidney cancer	1e-05	0.000198	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP1A1—kidney cancer	9.55e-06	0.000189	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTT1—kidney cancer	9.51e-06	0.000189	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ACHE—kidney cancer	9.51e-06	0.000189	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ABCB1—kidney cancer	9.47e-06	0.000188	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—POMC—kidney cancer	9.23e-06	0.000183	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTM1—kidney cancer	9.19e-06	0.000182	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SCARB1—kidney cancer	9.01e-06	0.000179	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTGS1—kidney cancer	8.92e-06	0.000177	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.79e-06	0.000174	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PSMD7—kidney cancer	8.74e-06	0.000173	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP1A1—kidney cancer	8.71e-06	0.000173	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—BCHE—kidney cancer	8.29e-06	0.000164	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.19e-06	0.000162	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—POMC—kidney cancer	7.98e-06	0.000158	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.91e-06	0.000157	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.85e-06	0.000156	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTGS2—kidney cancer	7.36e-06	0.000146	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.16e-06	0.000142	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—POMC—kidney cancer	7.12e-06	0.000141	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTP1—kidney cancer	6.59e-06	0.000131	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—POMC—kidney cancer	6.49e-06	0.000129	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTEN—kidney cancer	6.42e-06	0.000127	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTGS2—kidney cancer	6.37e-06	0.000126	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ABCB1—kidney cancer	6.24e-06	0.000124	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTM1—kidney cancer	6.06e-06	0.00012	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.75e-06	0.000114	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTGS2—kidney cancer	5.68e-06	0.000113	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTEN—kidney cancer	5.55e-06	0.00011	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTGS2—kidney cancer	5.18e-06	0.000103	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTEN—kidney cancer	4.95e-06	9.82e-05	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.53e-06	8.98e-05	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTEN—kidney cancer	4.52e-06	8.96e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—POMC—kidney cancer	4.28e-06	8.49e-05	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.92e-06	7.76e-05	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.5e-06	6.93e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTGS2—kidney cancer	3.42e-06	6.77e-05	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.19e-06	6.32e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTEN—kidney cancer	2.98e-06	5.91e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.1e-06	4.17e-05	CbGpPWpGaD
